Denali Therapeutics Inc (DNLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||
| Net Income | -16,788 | N/A | N/A |
| Depreciation Amortization | 121 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,678 | N/A | N/A |
| Other Working Capital | 426 | N/A | N/A |
| Other Operating Activity | -489 | 0 | 0 |
| Operating Cash Flow | $-15,052 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||
| PPE Investments | -3,062 | N/A | N/A |
| Investing Cash Flow | $-3,062 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||
| Debt Issued | 5,000 | N/A | N/A |
| Common Stock Issued | 620 | N/A | N/A |
| Other Financing Activity | 43,234 | 0 | 0 |
| Financing Cash Flow | $48,854 | $N/A | $N/A |
| End Cash Position | 30,740 | N/A | N/A |
| Net Cash Flow | $30,740 | $N/A | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -15,052 | N/A | N/A |
| Capital Expenditure | -3,062 | N/A | N/A |
| Free Cash Flow | -18,114 | 0 | 0 |